Omicron symptom: Is your scratchy throat coronavirus or a sore throat?
OMICRON has infected at least 45,000 people in the UK so far, and there are probably many more unreported cases as the mild symptoms of the variant cause cases to slip under the net. Is your scratchy throat coronavirus or just regular sore throat? (Source: Daily Express - Health)
Source: Daily Express - Health - December 22, 2021 Category: Consumer Health News Source Type: news
Omicron symptoms: What does a Covid sore throat feel like? 'A common symptom' explained
OMICRON symptoms might be slightly different to other variants of Covid, so it's really important to watch out for any new signs of infection. You could be at risk of Omicron if you develop a sore throat - what does the sore throat feel like? It's a "common sign" of Covid infection. (Source: Daily Express - Health)
Source: Daily Express - Health - December 21, 2021 Category: Consumer Health News Source Type: news
Early data show that cold-like symptoms most commonly reported by people with new Covid 19 omicron variant, BMJ
Initial analysis of data from the Covid Symptoms Study indicate the top five omicron infection symptoms reported in London were runny nose, headache, fatigue (either mild or severe), sneezing, and sore throat. UK government urged to update its list of symptoms for Covid-19. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 20, 2021 Category: Consumer Health News Source Type: news
Can you trust a negative lateral flow Covid test?
Analysis: with cold symptoms, it is better to wait for a PCR result rather than risk spreading the virusCoronavirus – latest updatesSee all our coronavirus coverageYou wake up with a pounding head, sore throat and runny nose: you reach for one of those lateral flow tests (LFT) you ’ve got stashed away, just to check it is not Covid. If it returns a single red line (negative), then most people will pop a couple of paracetamol and go about business as normal – particularly if you’ve been double-jabbed. It probably is just a cold, after all.Yet, the emergence of Omicron has thrown a spanner in the works. According to ...
Source: Guardian Unlimited Science - December 13, 2021 Category: Science Authors: Linda Geddes Science correspondent Tags: Coronavirus England UK news Science Infectious diseases Source Type: news
Quick Consult: Symptoms: Fever and Sore Throat
No abstract available (Source: Emergency Medicine News)
Source: Emergency Medicine News - December 1, 2021 Category: Emergency Medicine Tags: Quick Consult Source Type: news
Janssen Reports Positive Topline Week 48 Phase 2 Results for TREMFYA ® (guselkumab) in Adults With Moderately to Severely Active Crohn's Disease
SPRING HOUSE, PENNSYLVANIA, November 17, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced topline results from the Phase 2 GALAXI 1 clinical trial which showed rates of clinical remission (Crohn’s Disease Activity Index [CDAI]<150) previously reported at week 12 increased at week 48 among adults with moderately to severely active Crohn’s disease (CD) treated with TREMFYA® (guselkumab).1 At week 48, 65 percent of patients receiving TREMFYA achieved clinical remission. TREMFYA is under investigation and not currently approved for the treatment of CD in the U.S.2Janssen previously...
Source: Johnson and Johnson - November 17, 2021 Category: Pharmaceuticals Source Type: news
New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately to severely acti...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Surge in ‘worst colds ever’ among double-jabbed may be Covid breakthrough, warn scientists
BRITONS suffering from intense cold-like symptoms could be enduring breakthrough cases of the coronavirus without realising, lead scientists have warned. Symptoms of the cold, described by many as the "worst" they've "ever" experienced, include a runny nose, a sore throat, headaches, coughs and a loss of smell. (Source: Daily Express - Health)
Source: Daily Express - Health - October 11, 2021 Category: Consumer Health News Source Type: news
Janssen Submits Application Seeking U.S. FDA Approval of STELARA ® (ustekinumab) for the Treatment of Pediatric Patients With Juvenile Psoriatic Arthritis
HORSHAM, PENNSYLVANIA, October 8, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking expanded approval of STELARA® (ustekinumab) to treat pediatric patients ages 5 years and older with juvenile psoriatic arthritis (jPsA).The filing is supported by extrapolation of data from nine studies across both adult trials in active PsA and adult and pediatric studies in moderate to severe plaque psoriasis, totaling 3,997 patients evaluated across these closely associated dis...
Source: Johnson and Johnson - October 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
New Analysis Presented by Janssen at United European Gastroenterology Week (UEGW) Demonstrates Long-Term Safety Profile for STELARA ® (ustekinumab) in Older Patients Across Approved Indications
SPRING HOUSE, PENNSYLVANIA, October 4, 2021 – Today, the Janssen Pharmaceutical Companies of Johnson & Johnson announced a new analysis of STELARA® (ustekinumab) pooled safety data from 13 clinical studies across approved indications, showing rates of key safety events among adults 60 years and older treated with STELARA for up to five yearsa were similar to rates observed with placebo during the control phase of these trials.1,b Approved indications included adults with moderately to severely active Crohn’s disease (CD), moderately to severely active ulcerative colitis (UC), moderate to severe plaque psoriasis (P...
Source: Johnson and Johnson - October 4, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Cheshire mother, 41, reveals how says having coronavirus 'saved her life'
Jemma Falloon, 41, from Ellesmere Port, Cheshire suspected she had Long Covid as her sore throat continued for more than 12 weeks after having the virus, but her GP revealed it was cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - September 27, 2021 Category: Consumer Health News Source Type: news
Consumer Health: What is the flu?
Fever, upset stomach, diarrhea, sore throat, chills, coughing, sneezing and headache all can make you feel miserable. And when you're not feeling well, it sometimes can be hard to know exactly what's wrong and how you can help yourself feel better. With flu season approaching, this is a good time to look at the symptoms of what is — and is not — the flu. Common cold A runny or stuffy nose, sneezing, congestion, headache… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 22, 2021 Category: Databases & Libraries Source Type: news
What Home Remedies Get Rid of Sore Throat Quickly
What Home Remedies Get Rid of a Sore Throat Quickly? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - September 20, 2021 Category: General Medicine Source Type: news
Antihistamine poisoning: Seven warning signs you've taken too much hay fever medication
HAY FEVER can cause itchy, red watery eyes, sneezing fits, and a sore throat. If you find that taking an antihistamine isn't solving the problem, you might be tempted to try alternative methods. (Source: Daily Express - Health)
Source: Daily Express - Health - August 8, 2021 Category: Consumer Health News Source Type: news
STELARA ® (ustekinumab) Demonstrated Sustained Symptomatic and Corticosteroid-Free Remission Rates in Adults with Moderately to Severely Active Ulcerative Colitis at Nearly Three Years in Long-Term Extension of Phase 3 Trial
SPRING HOUSE, PENNSYLVANIA, July 9, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new three-year data from the long-term extension (LTE) of the STELARA® (ustekinumab) Phase 3 UNIFI study. The data demonstrated the majority (55.2 percent) of adult patients with moderately to severely active ulcerative colitis (UC) who initially responded to treatment with STELARA sustained symptomatic remissiona rates at nearly three years (week 152).1 Furthermore, a majority (96.4 percent) of the patients in symptomatic remissiona at week 152 were corticosteroid-free. These data are being presented...
Source: Johnson and Johnson - July 9, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news